Clever Leaves Holdings Inc. (CLVR): Price and Financial Metrics


Clever Leaves Holdings Inc. (CLVR): $0.59

-0.01 (-1.20%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add CLVR to Watchlist
Sign Up

Industry: Agriculture


Ranked

of

in industry

CLVR POWR Grades

  • CLVR scores best on the Sentiment dimension, with a Sentiment rank ahead of 84.32% of US stocks.
  • CLVR's strongest trending metric is Momentum; it's been moving down over the last 177 days.
  • CLVR's current lowest rank is in the Quality metric (where it is better than 3.54% of US stocks).

CLVR Stock Summary

  • With a market capitalization of $26,495,812, CLEVER LEAVES HOLDINGS INC has a greater market value than merely 8.27% of US stocks.
  • With a year-over-year growth in debt of -83.67%, CLEVER LEAVES HOLDINGS INC's debt growth rate surpasses merely 2.59% of about US stocks.
  • The volatility of CLEVER LEAVES HOLDINGS INC's share price is greater than that of 93.02% US stocks with at least 200 days of trading history.
  • If you're looking for stocks that are quantitatively similar to CLEVER LEAVES HOLDINGS INC, a group of peers worth examining would be SYTA, AMK, PHX, RIBT, and VISL.
  • CLVR's SEC filings can be seen here. And to visit CLEVER LEAVES HOLDINGS INC's official web site, go to www.cleverleaves.com.

CLVR Valuation Summary

  • CLVR's price/sales ratio is 1.4; this is 69.89% lower than that of the median Healthcare stock.
  • Over the past 46 months, CLVR's EV/EBIT ratio has gone NA NA.

Below are key valuation metrics over time for CLVR.

Stock Date P/S P/B P/E EV/EBIT
CLVR 2022-09-23 1.4 0.3 -0.6 -0.4
CLVR 2022-09-22 1.6 0.3 -0.7 -0.5
CLVR 2022-09-21 1.7 0.4 -0.7 -0.5
CLVR 2022-09-20 1.6 0.3 -0.7 -0.5
CLVR 2022-09-19 1.7 0.4 -0.8 -0.6
CLVR 2022-09-16 1.8 0.4 -0.8 -0.6

CLVR's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • CLVR has a Quality Grade of D, ranking ahead of 7.67% of graded US stocks.
  • CLVR's asset turnover comes in at 0.095 -- ranking 266th of 681 Pharmaceutical Products stocks.
  • 500 - Internal server error

The table below shows CLVR's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.095 0.618 -0.384
2021-03-31 0.073 0.612 -0.199
2020-12-31 0.086 0.612 -0.185
2020-12-31 0.086 0.612 -0.277
2020-09-30 0.029 0.529 -0.026
2020-09-30 0.000 NA 0.001

CLVR Price Target

For more insight on analysts targets of CLVR, see our CLVR price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $12.00 Average Broker Recommendation 1.5 (Moderate Buy)

CLVR Stock Price Chart Interactive Chart >

Price chart for CLVR

CLVR Price/Volume Stats

Current price $0.59 52-week high $7.65
Prev. close $0.60 52-week low $0.58
Day low $0.58 Volume 104,015
Day high $0.61 Avg. volume 3,280,185
50-day MA $0.85 Dividend yield N/A
200-day MA $1.45 Market Cap 25.58M

Clever Leaves Holdings Inc. (CLVR) Company Bio


Clever Leaves Holdings, Inc. operates as a holding company. It produces pharmaceutical-grade cannabinoids. The company was founded on July 23, 2020 and is headquartered in New York, NY.


CLVR Latest News Stream


Event/Time News Detail
Loading, please wait...

CLVR Latest Social Stream


Loading social stream, please wait...

View Full CLVR Social Stream

Latest CLVR News From Around the Web

Below are the latest news stories about CLEVER LEAVES HOLDINGS INC that investors may wish to consider to help them evaluate CLVR as an investment opportunity.

These 9 Cannabis Companies Are Leading The Way In Latin America: What Are They Up To And Why Should You Pay Attention?

The Benzinga Cannabis Capital Conference in Chicago, September 13-14, will celebrate the most recognized Latin American cannabis companies. This year's attendees will have the opportunity to meet the best Latin American brands in the industry that entered the emerging market and knew how to position themselves. Since then they have been growing in the industry and helping the cannabis community with their services. This article will take a look at nine companies that will surely be there joining

Yahoo | August 18, 2022

Analysts Have Been Trimming Their Clever Leaves Holdings Inc. (NASDAQ:CLVR) Price Target After Its Latest Report

Clever Leaves Holdings Inc. ( NASDAQ:CLVR ) last week reported its latest quarterly results, which makes it a good time...

Yahoo | August 14, 2022

Cantor Fitzgerald Sticks to Their Buy Rating for Clever Leaves Holdings (CLVR)

E ratio of -0.57.TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions.

Howard Kim on TipRanks | August 12, 2022

Clever Leaves Reports Second Quarter 2022 Results

Revenue Increased 27% Year-Over-Year to $4.7 Million, Reflecting Continued Commercial Momentum in Target Markets Significant Debt Reduction and Restructuring Initiatives Create Enhanced Capital Efficiency Reiterating 2022 Financial Guidance BOCA RATON, Fla., Aug. 11, 2022 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (Nasdaq: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, is reporting financial and o

Yahoo | August 11, 2022

EXCLUSIVE: Colombia Is About To Legalize Cannabis - And Exports May Land On Your Doorstep Soon, This CEO Says

Andres Fajardo is the CEO of Clever Leaves Holdings Inc. (NASDAQ: CLVR), one of the largest cannabis companies with operations in Canada, Colombia, Germany, Portugal and the United States. Clever is the first cannabis company in Latin America listed on Nasdaq with a European Union Good Manufacturing Practices Certification (EU GMP) for flowers and extracts. In Colombia, Clever Leaves has invested in the development of state-of-the-art infrastructure for the cultivation of pharmaceutical-grade ca

Yahoo | August 9, 2022

Read More 'CLVR' Stories Here

CLVR Price Returns

1-mo -26.42%
3-mo -42.72%
6-mo -71.22%
1-year -92.13%
3-year N/A
5-year N/A
YTD -80.97%
2021 -65.17%
2020 N/A
2019 N/A
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.4581 seconds.